BriaCell Therapeutics Corp. (BCTX)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jul. 15, 2025 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has submitted a correspondence to the SEC regarding its Registration Statement on Form S-1. The company is withdrawing its previous request for an acce… | Read Filing EDGAR |
| Jul. 15, 2025 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has requested to withdraw its request for an accelerated effective date for its Registration Statement on Form S-1. ThinkEquity LLC, acting as the plac… | Read Filing EDGAR |
| Jul. 14, 2025 | CORRESP | Neutral/Informational | Low | BriaCell Therapeutics Corp. has submitted a correspondence to the SEC regarding its Registration Statement on Form S-1. The correspondence indicates that ThinkEquity LLC, acting a… | Read Filing EDGAR |
| Jul. 14, 2025 | CORRESP | Neutral/Informational | Low | BriaCell Therapeutics Corp. has submitted a correspondence to the SEC regarding its Registration Statement on Form S-1. The company is withdrawing its previous request for an acce… | Read Filing EDGAR |
| Jul. 11, 2025 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has submitted a correspondence to the SEC regarding its Registration Statement on Form S-1. The company, through its placement agent ThinkEquity LLC, h… | Read Filing EDGAR |
| Jul. 11, 2025 | CORRESP | Neutral/Informational | Low | BriaCell Therapeutics Corp. has submitted a correspondence to the SEC regarding their Registration Statement on Form S-1. The company has withdrawn its previous request for an acc… | Read Filing EDGAR |
| Jul. 8, 2025 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1 to July 10, 2025. ThinkEquity LLC, acti… | Read Filing EDGAR |
| Jul. 8, 2025 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1. The company aims for the sta… | Read Filing EDGAR |
| Jun. 24, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to BriaCell Therapeutics Corp. that they do not intend to review the company's draft registration statement submitted on June 18, 2025. The SEC has reques… | Read Filing EDGAR |
| Apr. 22, 2025 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1. The company aims for the reg… | Read Filing EDGAR |
| Apr. 22, 2025 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has submitted a request for the acceleration of the effective date of their Registration Statement on Form S-1, aiming for it to be declared effective … | Read Filing EDGAR |
| Apr. 22, 2025 | CORRESP | Concern from SEC | Moderate | BriaCell Therapeutics Corp. submitted a response to the SEC's comments regarding their Draft Registration Statement on Form S-1. The SEC raised concerns about the company's promot… | Read Filing EDGAR |